Relative to its peers, ORGS does not have very much institutional sponsorship. The 7.74% of shares outstanding held by institutional investors is among the least of any stock in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GEODE CAPITAL MANAGEMENT LLC Bought 32.5 Thousand shares of Orgenesis Inc